Your browser doesn't support javascript.
loading
Ribosome biogenesis-based predictive biomarkers in endocrine therapy (Anastrozole) combined with mTOR inhibitor (Vistusertib) in endometrial cancer: translational study from the VICTORIA trial in collaboration with the GINECO group.
Mourksi, Nour-El-Houda; Dalban, Cécile; Colombe-Vermorel, Amélie; Odeyer, Laetitia; Simioni, Valentin; Frenel, Jean-Sébastien; Fabbro, Michel; Bazan, Fernando; Abadie-Lacourtoisie, Sophie; Coquan, Elodie; Martinez, Séverine; Garin, Gwenaelle; Tabone-Eglinger, Séverine; Treilleux, Isabelle; Chabaud, Sylvie; Pérol, David; Ray-Coquard, Isabelle; Heudel, Pierre-Etienne; Diaz, Jean-Jacques; Marcel, Virginie.
Afiliación
  • Mourksi NE; Centre de Recherche en Cancérologie de Lyon, Inserm U1052, CNRS UMR5286, Université Claude Bernard Lyon 1, Centre Léon Bérard, Université de Lyon, Lyon, France.
  • Dalban C; Institut Convergence PLAsCAN, Lyon, France.
  • Colombe-Vermorel A; DevWeCan Labex Laboratory, Lyon, France.
  • Odeyer L; Clinical Research Department, Centre Léon Bérard, Lyon, France.
  • Simioni V; Biopathology Department, Centre Léon Bérard, GINECO, Lyon, France.
  • Frenel JS; Biopathology Department, Centre Léon Bérard, GINECO, Lyon, France.
  • Fabbro M; Centre de Recherche en Cancérologie de Lyon, Inserm U1052, CNRS UMR5286, Université Claude Bernard Lyon 1, Centre Léon Bérard, Université de Lyon, Lyon, France.
  • Bazan F; Institut Convergence PLAsCAN, Lyon, France.
  • Abadie-Lacourtoisie S; DevWeCan Labex Laboratory, Lyon, France.
  • Coquan E; Medical Oncology Department, Institut Cancérologie de l'Ouest, and GINEGEPS, St Herblain, France.
  • Martinez S; Department of Surgical Oncology, Institut du Cancer de Montpellier, University of Montpellier, Montpellier, France.
  • Garin G; Department of Medical Oncology, University Hospital of Besançon, Besançon, France.
  • Tabone-Eglinger S; Institut de Cancérologie de l'Ouest, Angers, France.
  • Treilleux I; Department of Clinical Research, Department of Medical Oncology, Comprehensive Cancer Centre François Baclesse, Caen, France.
  • Chabaud S; Biological Resource Center, Centre Léon Bérard, Lyon, France.
  • Pérol D; Clinical Research Department, Centre Léon Bérard, Lyon, France.
  • Ray-Coquard I; Biological Resource Center, Centre Léon Bérard, Lyon, France.
  • Heudel PE; Biopathology Department, Centre Léon Bérard, GINECO, Lyon, France.
  • Diaz JJ; Clinical Research Department, Centre Léon Bérard, Lyon, France.
  • Marcel V; Clinical Research Department, Centre Léon Bérard, Lyon, France.
Mol Oncol ; 17(1): 27-36, 2023 01.
Article en En | MEDLINE | ID: mdl-36370117
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Neoplasias Endometriales Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Mol Oncol Asunto de la revista: BIOLOGIA MOLECULAR / NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Francia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Neoplasias Endometriales Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Mol Oncol Asunto de la revista: BIOLOGIA MOLECULAR / NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Francia